We are live on
!
Find out more
MJP
Michael J. Puzo Portfolio holdings
AUM
$343M
1-Year Est. Return
18.42%
This Fund
S&P 500
This Quarter
Est. Return
+6.24%
1 Year Est. Return
+18.42%
3 Year Est. Return
+60.27%
5 Year Est. Return
+82.68%
10 Year Est. Return
+283.93%
AUM
$300M
AUM Growth
+$22.8M
(+8.2%)
Cap. Flow
+$11.8M
Cap. Flow
% of AUM
3.95%
Top 10 Holdings %
Top 10 Hldgs %
38.69%
Holding
78
New
2
Increased
40
Reduced
21
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$2.09M |
| 2 |
Walt Disney
DIS
|
+$1.9M |
| 3 |
Nike
NKE
|
+$1.81M |
| 4 |
Amazon
AMZN
|
+$764K |
| 5 |
NVIDIA
NVDA
|
+$676K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$470K |
| 2 |
Chevron
CVX
|
+$248K |
| 3 |
ExxonMobil
XOM
|
+$232K |
| 4 |
Unilever
UL
|
+$223K |
| 5 |
Wells Fargo
WFC
|
+$206K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.22% |
| 2 | Technology | 25% |
| 3 | Industrials | 13.97% |
| 4 | Financials | 7.78% |
| 5 | Consumer Discretionary | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Pfizer
PFE
$143B
| $678K | 0.23% |
16,625
+3,300
| +25% | +$143K |
|
52
Colgate-Palmolive
CL
$74.8B
| $656K | 0.22% |
8,725
+1,600
| +22% | +$119K |
|
53
Bristol-Myers Squibb
BMY
$129B
| $586K | 0.2% |
8,450
-610
| -7% | -$43K |
|
54
ASML
ASML
$596B
| $560K | 0.19% |
+824
| New | +$529K |
|
55
Sysco
SYY
$40.8B
| $504K | 0.17% |
6,525
+1,125
| +21% | +$86.3K |
|
56
Dover
DOV
$26.7B
| $452K | 0.15% |
2,975
| – | – |
|
57
Bank OZK
OZK
$5.63B
| $449K | 0.15% |
13,135
-3,000
| -19% | -$126K |
|
58
Texas Instruments
TXN
$248B
| $409K | 0.14% |
2,200
| – | – |
|
59
Ecolab
ECL
$79.8B
| $368K | 0.12% |
2,225
| – | – |
|
60
Paychex
PAYX
$43.4B
| $349K | 0.12% |
3,050
+50
| +2% | +$5.69K |
|
|
61
Unilever
UL
$142B
| $337K | 0.11% |
5,777
-3,933
| -41% | -$223K |
|
62
Idexx Laboratories
IDXX
$44.9B
| $325K | 0.11% |
650
| – | – |
|
63
Bank of Montreal
BMO
$123B
| $312K | 0.1% |
3,500
| – | – |
|
64
Nucor
NUE
$58.3B
| $278K | 0.09% |
1,800
| – | – |
|
65
American Express
AXP
$224B
| $264K | 0.09% |
1,600
| – | – |
|
66
Coca-Cola
KO
$383B
| $256K | 0.09% |
4,125
| – | – |
|
67
Cisco
CSCO
$443B
| $245K | 0.08% |
4,682
+182
| +4% | +$8.89K |
|
68
Gilead Sciences
GILD
$165B
| $220K | 0.07% |
2,650
-50
| -2% | -$4.14K |
|
69
EOG Resources
EOG
$77.7B
| $202K | 0.07% |
1,765
-100
| -5% | -$12.1K |
|
70
Empire State Realty Series ES
ESBA
$1.57B
| $95.9K | 0.03% |
14,800
-1,400
| -9% | -$9.86K |
|
|
71
Wells Fargo
WFC
$254B
| – | – |
-5,000
| Closed | -$206K |
|
Similar funds
WP
LWM
CWM
BA
TCMNY
FMB
AWA
FCM
Michael J. Puzo's Q1 2023 Portfolio in Review
As of Q1 2023, Michael J. Puzo held 78 positions worth $300M, up 8.2% from $277M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Michael J. Puzo deployed $11.8M of net new capital in Q1 2023, opening 2 new positions and adding to 40 existing holdings. Its largest new stake was ASML: 824 shares worth $560K.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 27% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Intel, an estimated $470K trimmed.
- Michael J. Puzo's largest Q1 2023 buy was ASML: 824 shares worth $560K.
- Michael J. Puzo added most to Medtronic in Q1 2023, an estimated $2.09M increase.
- Michael J. Puzo's biggest Q1 2023 reduction was Intel, cutting an estimated $470K.
- Michael J. Puzo fully exited Wells Fargo in Q1 2023, selling an estimated $206K.
- Michael J. Puzo's ten largest holdings make up 39% of its $300M portfolio in Q1 2023.
- Michael J. Puzo opened 2 new positions and closed 1 in Q1 2023.
- Michael J. Puzo's portfolio value rose 8.2% quarter-over-quarter to $300M.
Based on Michael J. Puzo's 13F filing for Q1 2023, filed 11 May 2023.